Papers: 10.3390/pharmaceutics13040485

https://doi.org/10.3390/pharmaceutics13040485

A Model-Informed Drug Development (MIDD) Approach for a Low Dose of Empagliflozin in Patients with Type 1 Diabetes

Cited by: 2
Author(s): Curtis K. Johnston, Rena J. Eudy‐Byrne, Ahmed Elmokadem, Valerie Nock, Jan Marquard, Nima Soleymanlou, Matthew M. Riggs, Karl‐Heinz Liesenfeld
Published: over 5 years ago

Software Mentions 1